QA: RAPT Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001673772_2023_RAPT_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001673772, RAPT Therapeutics Inc.

  xvar xval
0 AssetsCurrent 252,694,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,539,000
3 remainder_Assets 10,976,000
4 LiabilitiesCurrent 14,224,000
5 LiabilitiesNoncurrent 6,819,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,240,000
9 ResearchAndDevelopmentExpense 67,082,000
10 remainder_Expenses 0
11 remainder_Revenues 1,527,000
12 remainder_NetIncome 1,957,000
13 remainder_ComprehensiveNetIncome 180,000
  yvar yval
0 Assets 266,209,000
1 Liabilities 21,043,000
2 Expenses 87,322,000
3 Revenues 1,527,000
4 StockholdersEquity 245,166,000
5 NetIncome -83,838,000
6 ComprehensiveNetIncome -83,748,000
7 BaseVar 189,119,000
8 EconomicCapitalRatio 2.35

Edgar->Model Mapping

Feature Distribution

Change over Time